Livestock producers worldwide face significant economic drain due to Fasciola hepatica infections, which compromise animal health and reduce milk and meat yield. Identifying a reliable China/Custom fascioliasis or fasciola hepatica factory is the critical first step in implementing a sustainable biosecurity strategy. Shijiazhuang Huajun Animal Pharmaceutical Co., Ltd. addresses these challenges by integrating advanced R&D with large-scale production, ensuring that complex parasitic threats are met with precision-engineered veterinary solutions.
Since our establishment in 2008, we have evolved into a high-tech powerhouse. Our 21,000-square-meter facility in the Xinle City East Industrial Park provides the infrastructure necessary to develop specific antigens and peptides tailored for fascioliasis control. By utilizing our 2022 Ministry of Agriculture GMP-certified production lines, we offer custom formulations that allow global distributors to provide targeted treatments that go beyond generic alternatives.
Quality assurance in the production of antiparasitics and diagnostic antigens requires rigorous adherence to international pharmacological benchmarks. As a leading China/Custom fascioliasis or fasciola hepatica factory, we leverage specialized production lines for powders, oral solutions, and solid mixed feed additives to ensure high bioavailability of active pharmaceutical ingredients.
| Performance Metric | Industry Significance | Our Engineering Standard | Advantage |
|---|---|---|---|
| Antigen Specificity | Prevents diagnostic cross-reactivity | High-purity peptide integration | Superior diagnostic accuracy for liver fluke |
| Regulatory Compliance | Ensures international market entry | 2022 New Veterinary Drug GMP | Seamless global export and safety trust |
| Formulation Diversity | Facilitates varied administration routes | 100+ product varieties (Liquid/Solid) | Adaptable treatment for poultry and cattle |
| Production Scale | Guarantees supply chain stability | 21,000 sqm dedicated facility | Rapid fulfillment of high-volume custom orders |
Our technical superiority is further evidenced by our multi-language operational capacity, supporting partners in Arabic, German, Russian, and Spanish, ensuring that technical specifications and usage protocols for Fasciola hepatica treatments are communicated with absolute clarity across the global supply chain.
Strategic procurement from a specialized China/Custom fascioliasis or fasciola hepatica factory transcends simple purchasing; it is an investment in long-term agricultural productivity. Shijiazhuang Huajun Animal Pharmaceutical Co., Ltd. focuses on value engineering by optimizing the concentration of active antiparasitic agents, thereby reducing the "cost per dose" while maximizing the therapeutic outcome.
By aligning with a factory that manages the entire lifecycle—from R&D of probiotics like Bacillus Coagulans SNZ 1969 to advanced antiparasitic delivery systems—clients gain a competitive edge. Our commitment to innovation ensures that your livestock management program remains resilient against evolving parasitic resistance, securing the financial future of your veterinary enterprise.
Related products
Top Selling Products
